These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26892105)

  • 1. Circulating Tumor Cells and Tumor Stem Cells Detection in the Peripheral Blood Mononuclear Cells of Breast Cancer.
    Wang F; Li YC; Liu LP; Zhang HM; Tong S
    J Clin Lab Anal; 2016 Sep; 30(5):616-22. PubMed ID: 26892105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].
    Zheng HY; Chen Q; Ye YB; Huang WW
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
    Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
    Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
    Cai QQ; Huang HQ; Lin TX; Jiang WQ
    Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
    Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
    Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients: relevance for circulating tumor cell detection.
    Wang L; Wang Y; Liu Y; Cheng M; Wu X; Wei H
    J Exp Clin Cancer Res; 2009 Apr; 28(1):57. PubMed ID: 19397830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-level expression of HER2 and CK19 in normal peripheral blood mononuclear cells: relevance for detection of circulating tumor cells.
    You F; Roberts LA; Kang SP; Nunes RA; Dias C; Iglehart JD; Solomon NA; Friedman PN; Harris LN
    J Hematol Oncol; 2008 May; 1():2. PubMed ID: 18577250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.
    Theodoropoulos PA; Polioudaki H; Agelaki S; Kallergi G; Saridaki Z; Mavroudis D; Georgoulias V
    Cancer Lett; 2010 Feb; 288(1):99-106. PubMed ID: 19619935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of circulating tumor cells in metastatic breast cancer patients.
    Sanislo L; Vertakova-Krakovska B; Kuliffay P; Brtko J; Galbava A; Galbavy S
    Endocr Regul; 2011 Jul; 45(3):113-24. PubMed ID: 21793623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
    Ignatiadis M; Xenidis N; Perraki M; Apostolaki S; Politaki E; Kafousi M; Stathopoulos EN; Stathopoulou A; Lianidou E; Chlouverakis G; Sotiriou C; Georgoulias V; Mavroudis D
    J Clin Oncol; 2007 Nov; 25(33):5194-202. PubMed ID: 17954712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer.
    Tunca B; Egeli U; Cecener G; Tezcan G; Gökgöz S; Tasdelen I; Bayram N; Tolunay S; Umut G; Demirdogen E; Erturk E; Ak S; Cetintas S; Evrensel T
    Tumori; 2012; 98(2):243-51. PubMed ID: 22677992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary investigation of the relationship between circulating tumor cells and cancer stem cells in patients with breast cancer.
    Wang J; Cao MG; You CZ; Wang CL; Liu SL; Kai C; Dou J
    Cell Mol Biol (Noisy-le-grand); 2012 Feb; 58 Suppl():OL1641-5. PubMed ID: 22340707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
    Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y
    Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct expression of cytokeratin, N-cadherin and CD133 in circulating tumor cells of metastatic breast cancer patients.
    Bock C; Rack B; Huober J; Andergassen U; Jeschke U; Doisneau-Sixou S
    Future Oncol; 2014 Aug; 10(10):1751-65. PubMed ID: 25303055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.
    Mikulová V; Cabiňaková M; Janatková I; Mestek O; Zima T; Tesařová P
    Scand J Clin Lab Invest; 2014 Mar; 74(2):132-42. PubMed ID: 24350991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of CD44+CD24- cells on non-sentinel axillary lymph node metastases in sentinel node-positive breast cancer.
    Nogi H; Suzuki M; Kamio M; Kato K; Kawase K; Toriumi Y; Takeyama H; Fukushima H; Morikawa T; Uchida K
    Oncol Rep; 2011 Apr; 25(4):1109-15. PubMed ID: 21308353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of suspension array assay to detect marker genes expression of circulating tumor cells for early prediction of breast cancer metastasis].
    Ke F; Wu JM; Yao JE; Bai YJ; Guo AL
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2257-61. PubMed ID: 18001545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor cells in breast cancer beyond the genotype of primary tumor for tailored therapy.
    Ren C; Han C; Fu D; Wang D; Chen H; Chen Y; Shen M
    Int J Cancer; 2016 Apr; 138(7):1586-600. PubMed ID: 26178386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription-polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features.
    Skondra M; Gkioka E; Kostakis ID; Pissimissis N; Lembessis P; Pectasides D; Koutsilieris M
    Anticancer Res; 2014 Nov; 34(11):6691-9. PubMed ID: 25368276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of circulating breast cancer cell heterogeneity and interactions with peripheral blood mononuclear cells.
    Brechbuhl HM; Vinod-Paul K; Gillen AE; Kopin EG; Gibney K; Elias AD; Hayashi M; Sartorius CA; Kabos P
    Mol Carcinog; 2020 Oct; 59(10):1129-1139. PubMed ID: 32822091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.